PYGL Antibody

Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties. Activity of phosphorylase is controlled both by allosteric means (through the noncovalent binding of metabolites) and by covalent modification. Thus AMP allosterically activates, whereas ATP, ADP, and glucose 6 phosphate allosterically inhibit, phosphorylase B.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 application: WB.

Showing Publications 1 - 2 of 2.

Publications using NBP1-86182	Applications	Species
Shu Y, Zou C, Cai Y et al. Vitamin C deficiency induces hypoglycemia and cognitive disorder through S-nitrosylation-mediated activation of glycogen synthase kinase 3 beta Redox biology 2022-08-08 [PMID: 35969998] (WB) Details: Dilutions: 1:1000	WB
Nogales-Gadea G, Mormeneo E, Garcia-Consuegra I et al. Expression of glycogen phosphorylase isoforms in cultured muscle from patients with McArdle's disease carrying the p.R771PfsX33 PYGM mutation. PLoS One 2010-10-01 [PMID: 20957198]

Array NBP1-86182

• PYGL Antibodies
• PYGL ELISA Kits
• PYGL Lysate
• PYGL Proteins